Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[18F ]l-DOPA
- 3 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 334 (1) , 31-38
- https://doi.org/10.1016/s0014-2999(97)01157-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of Catechol-O-methyltransferase Inhibition on the Rates of Uptake and Reversibility of 6-Fluoro-l-Dopa Trapping in MPTP-induced Parkinsonism in MonkeysNeuropharmacology, 1997
- Improved Therapy of Parkinsonʼs Disease with Tolcapone, a Central and Peripheral COMT Inhibitor with an S-Adenosyl-L-Methionine-Sparing EffectClinical Neuropharmacology, 1994
- Pharmacokinetics of Plasma 6-[18F]Fluoro-l-3,4-Dihydroxyphenylalanine ([18F]FDOPA) in HumansJournal of Cerebral Blood Flow & Metabolism, 1993
- Routine determination of [18F]-L-6-fluorodopa and its metabolites in blood plasma is essential for accurate positron emission tomography studiesLife Sciences, 1992
- Distribution and Kinetics of 3-O-Methyl-6-[18F]fluoro-L-DOPA in the Rhesus Monkey BrainJournal of Cerebral Blood Flow & Metabolism, 1991
- 6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structuresJournal of Neuroscience Research, 1990
- THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSON'S DISEASE, STUDIED WITH PETBrain, 1990
- Selegiline Use to Prevent Progression of Parkinson's DiseaseArchives of Neurology, 1989
- Synthesis of some novel potent and selective catechol O-methyltransferase inhibitorsJournal of Medicinal Chemistry, 1989
- Engineering Developments on the UBC-TRIUMF Modified PETT VI Positron Emission TomographIEEE Transactions on Nuclear Science, 1983